Your browser doesn't support javascript.
loading
Effect of apheresis plasma donation on plasma uric acid levels, the lipid profile, and major plasma proteins in plasma donors in China: A multicenter, prospective cohort study.
Liu, Qing; Liu, Fengjuan; Sun, Pan; Du, Xi; Zhu, Liyuan; Xu, Jun; Cheng, Lu; Huang, Yaojing; Huang, Chunyan; Chen, Jielin; Wang, Zhibo; Lu, Aihong; Zhu, Yikuan; Huang, Huan; Huang, Junli; Pan, Jufeng; Ma, Li; Wang, Zongkui; Li, Changqing.
Afiliação
  • Liu Q; Department of Plasma Proteins, Institute of Blood Transfusion, Chinese Academy of Medical Sciences & Peking Union Medical College, Chengdu, PR China.
  • Liu F; Department of Plasma Proteins, Institute of Blood Transfusion, Chinese Academy of Medical Sciences & Peking Union Medical College, Chengdu, PR China.
  • Sun P; Department of Plasma Proteins, Institute of Blood Transfusion, Chinese Academy of Medical Sciences & Peking Union Medical College, Chengdu, PR China.
  • Du X; Department of Plasma Proteins, Institute of Blood Transfusion, Chinese Academy of Medical Sciences & Peking Union Medical College, Chengdu, PR China.
  • Zhu L; Department of Plasma Proteins, Institute of Blood Transfusion, Chinese Academy of Medical Sciences & Peking Union Medical College, Chengdu, PR China.
  • Xu J; Research and Development Department, Shanghai RAAS Blood Products Co., Ltd., Shanghai, PR China.
  • Cheng L; Research and Development Department, Shanghai RAAS Blood Products Co., Ltd., Shanghai, PR China.
  • Huang Y; Research and Development Department, Bama RAAS Apheresis Plasma Co., Ltd., Bama, Guangxi, PR China.
  • Huang C; Research and Development Department, Bama RAAS Apheresis Plasma Co., Ltd., Bama, Guangxi, PR China.
  • Chen J; Research and Development Department,Guangdong Shuanglin Bio-pharmacy Co., Ltd., Zhanjiang, PR China.
  • Wang Z; Research and Development Department,Guangdong Shuanglin Bio-pharmacy Co., Ltd., Zhanjiang, PR China.
  • Lu A; Research and Development Department, Suixi Shuanglin Apheresis Plasma Co.,Ltd., Suixi, Guangdong, PR China.
  • Zhu Y; Research and Development Department, Lianjiang Shuanglin Apheresis Plasma Co.,Ltd., Lianjiang, Guangdong, PR China.
  • Huang H; Research and Development Department, Lianjiang Shuanglin Apheresis Plasma Co.,Ltd., Lianjiang, Guangdong, PR China.
  • Huang J; Research and Development Department, Pingguo Weiguang Apheresis Plasma Co.,Ltd., Pingguo, Guangxi, PR China.
  • Pan J; Research and Development Department, Wuming RAAS Apheresis Plasma Co.,Ltd., Wuming, Guangxi, PR China.
  • Ma L; Department of Plasma Proteins, Institute of Blood Transfusion, Chinese Academy of Medical Sciences & Peking Union Medical College, Chengdu, PR China. Electronic address: mary@ibt.pumc.edu.cn.
  • Wang Z; Department of Plasma Proteins, Institute of Blood Transfusion, Chinese Academy of Medical Sciences & Peking Union Medical College, Chengdu, PR China. Electronic address: zongkui.wang@ibt.pumc.edu.cn.
  • Li C; Department of Plasma Proteins, Institute of Blood Transfusion, Chinese Academy of Medical Sciences & Peking Union Medical College, Chengdu, PR China. Electronic address: lichangqing268@163.com.
Transfus Apher Sci ; 63(4): 103940, 2024 Aug.
Article em En | MEDLINE | ID: mdl-38781881
ABSTRACT
Abnormal plasma uric acid (UA) levels, the lipid profile, and plasma proteins in blood are associated with a range of adverse health outcomes. This multicenter, prospective cohort study aimed to determine the possible effects of multiple apheresis plasma donations on plasma UA levels, the lipid profile, and major proteins in plasma donors. Participants were enrolled from 1 April 2021 to 31 August 2022. When their plasma UA (men >420 µmol/L, women >360 µmol/L) and/or lipid levels (total cholesterol [TC] ≥6.2 mmol/L, triglycerides [TGs] ≥2.3 mmol/L, low-density lipoprotein cholesterol ≥4.1 mmol/L, or high-density lipoprotein cholesterol [HDL-C] <1.0 mmol/L) were abnormal at their first plasma donation, the enrolled participants were followed up until they had completed 10 plasma donations. A total of 11485 participants were enrolled, of whom 1861 met the inclusion criteria. During the study period, 320 donors completed 10 plasma donations. None of the participants took any corrective medicine for their abnormal index. The measured parameters were significantly different from the first to the tenth plasma donations (donors with asymptomatic hyperuricemia UA, P < 0.001; donors with asymptomatic hyperlipidemia HDL-C, P < 0.001; TC, P = 0.025; TGs, P < 0.001; apolipoprotein B, P = 0.025; all of the plasma donors, immunoglobulin G, P < 0.001). The levels of HDL-C, TC, and apolipoprotein B were increased, and the levels of UA, TGs, and immunoglobulin G were decreased over this time. However, immunoglobulin G levels were still in the normal range. Moreover, the changes in these parameters were closely associated with the frequency of plasma donation during the study period. Repeated apheresis plasma donations can reduce plasma UA and TG levels and increase HDL-C levels; and further evaluation of the clinical significance with a larger sample size is required.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Ácido Úrico / Remoção de Componentes Sanguíneos / Doadores de Sangue / Proteínas Sanguíneas / Lipídeos Limite: Adult / Female / Humans / Male / Middle aged País como assunto: Asia Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Ácido Úrico / Remoção de Componentes Sanguíneos / Doadores de Sangue / Proteínas Sanguíneas / Lipídeos Limite: Adult / Female / Humans / Male / Middle aged País como assunto: Asia Idioma: En Ano de publicação: 2024 Tipo de documento: Article